Marie‐Pierre David

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

Alberto Papi, Michael G. Ison, Joanne M. Langley et al. · New England Journal of Medicine · 2023 · 748 citations · Full text

Veterinary Medicine, Geriatric Medicine, Infectious Diseases +17

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

Aimée R. Kreimer, Frank Struyf, Maria Rowena Del Rosario‐Raymundo et al. · The Lancet Oncology · 2015 · 303 citations · Full text

Veterinary Medicine, Immunology, Immunization +16

Correlation between direct ELISA, single epitope-based inhibition ELISA and Pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine

Francis Dessy, Sandra L. Giannini, Catherine Bougelet et al. · Human Vaccines · 2008 · 177 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

Michael G. Ison, Alberto Papi, Eugene Athan et al. · Clinical Infectious Diseases · 2024 · 162 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆

Marie‐Pierre David, Koen Van Herck, Karin Hardt et al. · Gynecologic Oncology · 2009 · 154 citations

Medicine, Immunology, Oncology +17